Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-002141

Senior VP - CCO sold 954 shares at $9.20 ($8,777)

  • Senior VP - CCO acquired 954 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Powell Lynne · Senior VP - CCO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-14 Exercise or conversion : show line 1 in the form +954 $3.22 $3,072 954 D
2019-01-14 Sale : show line 2 in the form −954 $9.20 $8,777 0 D
Open-market sales · 954 sh · avg $9.20 · $8,777

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-01-14 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −954 96,473 D
Loading xslF345X03/form4.xml…